Potential Molecular Mechanism of Guishao Pingchan Recipe in the Treatment of Parkinson's Disease Based on Network Pharmacology and Molecular Docking

被引:0
|
作者
Tan, Li-Juan [1 ]
Yu, Ying [2 ]
Fang, Ze-Hai [3 ]
Zhang, Jiong-Lu [1 ]
Huang, Hai-Liang [4 ]
Liu, Hong-Jie [1 ]
机构
[1] Jinan Univ, Sch Tradit Chinese Med, Guangzhou 510632, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Innovat Inst Chinese Med & Pharm, Jinan, Peoples R China
[3] Zibo Vocat Inst, Sch Nursing, Zibo, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Coll Rehabil Med, Jinan 250355, Peoples R China
基金
中国国家自然科学基金;
关键词
Guishao Pingchan Recipe; Parkinson's disease; network pharmacology; molecular docking; biological information; ALPHA-SYNUCLEIN; BRAIN; INJURY; TETRAMETHYLPYRAZINE; NEUROPROTECTION; PAEONIFLORIN; DYSFUNCTION; PREDICTION; APOPTOSIS; PATHWAY;
D O I
10.1177/1934578X221118486
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: To investigate the potential mechanism of Guishao Pingchan Recipe (GPR) against Parkinson's disease (PD) based on network pharmacology and molecular docking. Methods: The main components of GPR were collected based on TCMSP database, Batman-TCM database, Chinese Pharmacopoeia, and Literatures. The potential therapeutic targets of PD were predicted by Drug Bank Database and Gene Cards database. Cytoscape 3.8.2 software was used to construct herb-component-target network. Then, String database was used to construct a PPI network, and DAVID database was used for gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotation of targets function. Core components of GPR and hub targets were imported into AutoDock Vina for molecular docking verification and results were visualized by Pymol. Results: 13 candidate components were selected and 288 corresponding targets of GPR for treating PD were obtained. The GO enrichment analysis mainly involved 135 cell components, 187 molecular functions, and 1753 biological processes. Moreover, KEGG pathway enrichment analysis mainly involved 200 signaling pathways. Molecular docking simulation indicated a good binding ability of components and targets. Conclusion: Based on network pharmacology and molecular docking, we found that sitosterol, 4-Cholesten-3-one and stigmasterol in GPR could combine with MAPK3, APP, VEGFA, and CXCR4 and involved in the cAMP, PI3K/Akt, Rap1 signaling pathways. It is suggested that GPR may have therapeutic effects on PD through multi-component, multi-target, and multi-pathway and predict the relevant mechanism of the anti-PD effect of GPR.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Mechanism of Tianma Gouteng Decoction in the treatment of Parkinson's disease based on network pharmacology and molecular docking
    Ni, Pengyun
    Zhao, Bingbing
    Pang, Yu
    Pan, Kaiting
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (01): : 596 - 611
  • [2] Molecular mechanism of Acanthopanax senticosus in the treatment of Alzheimer's disease based on network pharmacology and molecular docking
    Kuang, Feng
    Xiang, Tao
    MOLECULAR DIVERSITY, 2023, 27 (06) : 2849 - 2865
  • [3] Molecular mechanism of Acanthopanax senticosus in the treatment of Alzheimer’s disease based on network pharmacology and molecular docking
    Feng Kuang
    Tao Xiang
    Molecular Diversity, 2023, 27 : 2849 - 2865
  • [4] Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking
    Jie Su
    Mengmeng Huo
    Fengnan Xu
    Liqiong Ding
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 1551 - 1559
  • [5] Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking
    Hu, Yaling
    Liu, Shuang
    Liu, Wenyuan
    Zhang, Ziyuan
    Liu, Yuxiang
    Li, Sufen
    Sun, Dalin
    Zhang, Guang
    Fang, Jingai
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 943 - 962
  • [6] Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking
    Su, Jie
    Huo, Mengmeng
    Xu, Fengnan
    Ding, Liqiong
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (03) : 1551 - 1559
  • [7] Network Pharmacology and Molecular Docking-Based Prediction of the Molecular Targets and Signaling Pathways of Ginseng in the Treatment of Parkinson's Disease
    Zhang, Wei
    Chen, Jingya
    Liu, Hongquan
    NATURAL PRODUCT COMMUNICATIONS, 2022, 17 (05)
  • [8] The Potential Mechanism of Liujunzi Decoction in the Treatment of Breast Cancer based on Network Pharmacology and Molecular Docking Technology
    Sun, Mei
    Lv, Feng
    Qin, Chunmeng
    Du, Dan
    Li, Wenjun
    Liu, Songqing
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (09) : 702 - 726
  • [9] Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking
    Ruan, Xiaofeng
    Du, Peng
    Zhao, Kang
    Huang, Jucun
    Xia, Hongmei
    Dai, Dan
    Huang, Shu
    Cui, Xiang
    Liu, Liming
    Zhang, Jianjun
    CHINESE MEDICINE, 2020, 15 (01) : 1V
  • [10] Molecular mechanism of Epicedium treatment for depression based on network pharmacology and molecular docking technology
    Dong, Yankai
    Tao, Bo
    Xue, Xing
    Feng, Caixia
    Ren, Yating
    Ma, Hengyu
    Zhang, Junli
    Si, Yufang
    Zhang, Sisi
    Liu, Si
    Li, Hui
    Zhou, Jiahao
    Li, Ge
    Wang, Zhifei
    Xie, Juanping
    Zhu, Zhongliang
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2021, 21 (01)